Pfizer to invest $120M at Kalamazoo facility for COVID-19 antiviral treatment
Pfizer Inc. has planned a $120 million investment at its Kalamazoo manufacturing facility to support the production of its COVID-19 antiviral treatment, Paxlovid.
Feeding Systems Deliver Continuous Production
The feeding systems are a key part of the new continuous production concept. At Pfizer, the compact arrangement of pharmaceutical feeders supplied by Coperion K-Tron accurately deliver ingredients into the continuous mixing process, thereby guaranteeing consistent and very high quality end products.
